{
  "id": "LAB-GLUC-HYPO-002",
  "name": "Hipoglicemia Moderada",
  "category": "LAB",
  "subcategory": "GLUCOSE",
  "description": "Alerta para hipoglicemia moderada 40-53 mg/dL com sintomas significativos",
  "version": "1.0.0",
  "created": "2026-02-06",
  "updated": "2026-02-06",
  "author": "Clinical Alert Specialist",
  "status": "active",
  "priority": "HIGH",
  "clinicalRationale": "Hipoglicemia moderada (40-53 mg/dL) causa sintomas neurogênicos (tremor, sudorese, palpitações) e neuroglicopênicos (confusão, dificuldade de concentração) significativos. Requer tratamento urgente com carboidratos de ação rápida conforme protocolo ADA 2024 regra dos 15-15.",
  "inputVariables": [
    {
      "name": "glicemia",
      "type": "number",
      "unit": "mg/dL",
      "description": "Glicemia sérica",
      "required": true,
      "normalRange": "70-100 mg/dL (fasting)"
    }
  ],
  "outputVariables": [
    {
      "name": "nivelAlerta",
      "type": "string",
      "values": ["Alerta", "Atencao", "OK"]
    },
    {
      "name": "urgencia",
      "type": "string",
      "values": ["URGENTE", "NORMAL"]
    },
    {
      "name": "classificacao",
      "type": "string"
    },
    {
      "name": "tendencia",
      "type": "string"
    },
    {
      "name": "acaoRequerida",
      "type": "string"
    },
    {
      "name": "justificativaCientifica",
      "type": "string"
    }
  ],
  "references": [
    "ADA Standards of Medical Care in Diabetes 2024",
    "American Diabetes Association: The 15-15 Rule for Hypoglycemia",
    "Cryer PE. Hypoglycemia in diabetes: pathophysiology, prevalence, and prevention. 2022"
  ],
  "tags": ["high-priority", "glucose", "hypoglycemia", "moderate", "15-15-rule", "neuroglycopenia"]
}
